详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Insights into the impact of sodium-glucose cotransporter 2 inhibition on urinary tract malignancy: A two-sample Mendelian randomization

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. [2]Department of Oncology/Department of Epidemiology and Medical Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. [3]School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [4]Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.

出处：

DOI：

ISSN：

关键词： Mendelian randomization prostate cancer bladder cancer renal cell carcinoma sodium-glucose cotransporter 2

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2024]版：

无

最新[2023]版：

大类 | 2 区医学

小类 | 2 区内分泌学与代谢

第一作者：

第一作者机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

通讯作者：

通讯机构： [1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. [4]Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China. [*1]Department of Urology, Institute of Urology, West China Hospital, Sichuan University, 88 South Keyuan Road, Chengdu, 610041, China [*2]Department of Endocrinology and Metabolism, Division of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses [2]Do Obesity-Related Traits Affect Prostate Cancer Risk through Serum Testosterone? A Mendelian Randomization Study [3]Nanomedicine for urologic cancers: diagnosis and management. [4]Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study [5]Coffee Consumption and Prostate Cancer Risk: Results from National Health and Nutrition Examination Survey 1999-2010 and Mendelian Randomization Analyses. [6]泌尿男生殖系统同时性三重癌1例报告 [7]Absence of causal relationship between Parkinson's disease and subsequent prostate cancer: evidence from meta-analysis and Mendelian randomization studies [8]Editorial: Biomarkers and immunotherapy for genitourinary tumors [9]Case report: Synchronous prostate cancer and renal cell carcinoma with prostate cancer-origin metastases to adrenal and renal hilar lymph nodes [10]Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma